Institute of Bone and Joint Research, Royal North Shore hospital, St Leonards, Sydney, New South Wales, Australia.
Clin Endocrinol (Oxf). 2008 Feb;68(2):290-8. doi: 10.1111/j.1365-2265.2007.03040.x. Epub 2007 Sep 14.
To investigate whether absence of secondary hyperparathyroidism in the presence of hypovitaminosis D has altered bone turnover, fracture risk and mortality.
A prospective cohort study.
A total of 1280 older men and women living in residential care facilities.
We measured baseline serum 25-hydroxyvitamin D (25OHD), serum intact PTH, serum amino-terminal propeptide of type I collagen (PINP) and serum carboxy-terminal telopeptide of type I collagen (CTX-I). Deaths and fractures were recorded prospectively.
Hypovitaminosis D (25OHD < 39 nmol/l) and absence of secondary hyperparathyroidism (PTH > 7.0 pmol/l) in the presence of hypovitaminosis D were common in this sample with a prevalence of 77.5% and 53.3%, respectively. In the presence of hypovitaminosis D, residents showing a hyperparathyroid response (n = 406) had significantly higher serum bone turnover markers than individuals with serum PTH levels < or = 7.0 pmol/l (termed 'low vitamin D, normal PTH', n = 463). After adjusting for risk factors, mortality was significantly higher in the secondary hyperparathyroidism group than in the 'low vitamin D, normal PTH' group [hazard ratio (HR) = 1.35, 95% confidence interval (CI) 1.12-1.64; P = 0.002]. All residents with serum PTH levels < or = 7.0 pmol/l (n = 603) were similar with regard to both bone turnover and mortality, independent of their actual vitamin D status.
Absence of secondary hyperparathyroidism in the presence of hypovitaminosis D appears to be common in the frail elderly and is associated with longer survival, similar to that observed in vitamin D-replete elderly subjects.
研究在维生素 D 缺乏的情况下,是否存在继发性甲状旁腺功能亢进症会改变骨转换、骨折风险和死亡率。
前瞻性队列研究。
1280 名居住在养老院的老年男性和女性。
我们测定了基线血清 25-羟维生素 D(25OHD)、血清全段甲状旁腺素(PTH)、血清Ⅰ型胶原氨基端前肽(PINP)和血清Ⅰ型胶原羧基端肽(CTX-I)。前瞻性记录死亡和骨折事件。
本研究样本中,维生素 D 缺乏(25OHD<39 nmol/l)和维生素 D 缺乏时存在继发性甲状旁腺功能亢进症(PTH>7.0 pmol/l)的情况均很常见,发生率分别为 77.5%和 53.3%。在维生素 D 缺乏的情况下,甲状旁腺激素反应性增高的患者(n = 406)的血清骨转换标志物水平明显高于 PTH 水平<或=7.0 pmol/l 的患者(称为“低维生素 D,正常 PTH”,n = 463)。校正了其他危险因素后,继发性甲状旁腺功能亢进症组的死亡率明显高于“低维生素 D,正常 PTH”组[危险比(HR)=1.35,95%置信区间(CI)1.12-1.64;P=0.002]。所有 PTH 水平<或=7.0 pmol/l 的患者(n = 603),无论其实际维生素 D 状态如何,其骨转换和死亡率均相似。
在维生素 D 缺乏的情况下,存在继发性甲状旁腺功能亢进症似乎在体弱的老年人中很常见,并且与维生素 D 充足的老年患者观察到的结果相似,提示预后较好。